Deloitte strengthens its Public Health Transformation Capabilities with acquisition of End Point's Industry-Leading Disease Surveillance Business
Acquiring Company
Deloitte
Acquired Company
Endpoint Health
London
Palo AltoOtherArtificial IntelligenceConsultingPublic SafetyBiotechnologySoftwareHealth CareDescription
Deloitte has bolstered its Public Health Transformation team by acquiring substantially all of the assets of End Point's industry-leading disease surveillance business, CasePointer. This acquisition brings experienced public health professionals, skilled software engineers, cloud developers, DevOps engineers, and epidemiologists to Deloitte, enhancing its service offerings for government clients. Together, Deloitte and End Point will enable public health agencies to better identify, investigate, and mitigate communicable diseases, environmental hazards, and bioterrorism events, while fortifying their emergency response efforts.
Quick answer
Deloitte is acquiring Endpoint Health, announced June 3, 2024. Deloitte is based in London, England, United Kingdom.
- How much did Deloitte pay for Endpoint Health?
- The deal value was not disclosed.
- What does Deloitte do?
- Deloitte drives progress.
- Where are Deloitte and Endpoint Health based?
- Deloitte is based in London, England, United Kingdom. Endpoint Health is based in Palo Alto, California, United States.
- Who are the decision-makers at Deloitte?
- Fundz holds 5 contacts at Deloitte. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who to call at Deloitte, and when
When Deloitte changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Deloitte raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Deloitte, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Deloitte. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Deloitte makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Endpoint Health?
Endpoint Health was acquired by Deloitte, based in London. The deal was reported on June 3, 2024. Deloitte drives progress. Our firms around the world help clients become leaders wherever they choose to compete. Deloitte is privately held and operates in Other.
When did Deloitte acquire Endpoint Health?
Deloitte's acquisition of Endpoint Health was reported on June 3, 2024. Deloitte has bolstered its Public Health Transformation team by acquiring substantially all of the assets of End Point's industry-leading disease surveillance business, CasePointer. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Endpoint Health do?
Endpoint Health is a Precision-FirstTM therapeutics company dedicated to addressing unmet needs in immune-mediated acute and chronic diseases. It is privately held, operating in Biotechnology, and is based in Palo Alto.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.